Taiwan Liposome Company financials at a glance
| Year | Year | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2010 | 2009 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
NT$78.23M | NT$240.66M | NT$158.64M | NT$95.92M | NT$59.77M | NT$41.67M | NT$49.64M | NT$62.32M | NT$209.14M | NT$101.93M | NT$0.00M | NT$36.65M | NT$25.97M | NT$0.00M |
| GM % | Gross Margin % |
|
100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 100.00% | 100.00% | 0.00% |
| OM | Operating Margin |
|
-287.77% | -79.30% | -258.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
NT$0.00 | NT$0.00 | ||||||||||||
| Div. | Dividends |
|
NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 | NT$0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
34.47m | 39.37m | 54.16m | 55.35m | 55.29m | 51.01m | 56.2m | 63.72m | 74.19m | 79.44m | 84.15m | 0m | 0m | 0m |
| OCF | Operating Cash Flow |
|
NT$-235.08M | NT$-63.32M | NT$-360.21M | NT$-466.57M | NT$-530.65M | NT$-607.72M | NT$-819.14M | NT$-686.04M | NT$-777.56M | NT$-875.19M | NT$0.00M | NT$-129.71M | NT$-153.21M | NT$0.00M |
| FCF | Free Cash Flow |
|
NT$-253.15M | NT$-118.15M | NT$-431.48M | NT$-516.45M | NT$-609.26M | NT$-627.66M | NT$-837.27M | NT$-752.75M | NT$-833.15M | NT$-907.35M | NT$0.00M | NT$-143.67M | NT$-213.33M | NT$0.00M |
| FCFS | Free Cash Flow Per Share |
|
NT$-8.54 | NT$-2.79 | NT$-8.89 | NT$-9.46 | NT$-11.13 | NT$-11.45 | NT$-15.22 | NT$-12.05 | NT$-12.78 | NT$-11.51 | NT$0.00 | NT$-6.94 | NT$-10.39 | NT$0.00 |